Division of Biomedical Sciences, Pharmacology and Cell Physiology Research Group, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
Hypertension. 2012 Apr;59(4):877-84. doi: 10.1161/HYPERTENSIONAHA.111.187427. Epub 2012 Feb 21.
KCNQ4-encoded voltage-dependent potassium (Kv7.4) channels are important regulators of vascular tone that are severely compromised in models of hypertension. However, there is no information as to the role of these channels in responses to endogenous vasodilators. We used a molecular knockdown strategy, as well as pharmacological tools, to examine the hypothesis that Kv7.4 channels contribute to β-adrenoceptor-mediated vasodilation in the renal vasculature and underlie the vascular deficit in spontaneously hypertensive rats. Quantitative PCR and immunohistochemistry confirmed gene and protein expression of KCNQ1, KCNQ3, KCNQ4, KCNQ5, and Kv7.1, Kv7.4, and Kv7.5 in rat renal artery. Isoproterenol produced concentration-dependent relaxation of precontracted renal arteries and increased Kv7 channel currents in isolated smooth muscle cells. Application of the Kv7 blocker linopirdine attenuated isoproterenol-induced relaxation and current. Isoproterenol-induced relaxations were also reduced in arteries incubated with small interference RNAs targeted to KCNQ4 that produced a ≈60% decrease in Kv7.4 protein level. Relaxation to isoproterenol and the Kv7 activator S-1 were abolished in arteries from spontaneously hypertensive rats, which was associated with ≈60% decrease in Kv7.4 abundance. This study provides the first evidence that Kv7 channels contribute to β-adrenoceptor-mediated vasodilation in the renal vasculature and that abrogation of Kv7.4 channels is strongly implicated in the impaired β-adrenoceptor pathway in spontaneously hypertensive rats. These findings may provide a novel pathogenic link between arterial dysfunction and hypertension.
KCNQ4 编码的电压依赖性钾 (Kv7.4) 通道是血管张力的重要调节剂,在高血压模型中严重受损。然而,关于这些通道在对内源性血管扩张剂反应中的作用尚不清楚。我们使用分子敲低策略以及药理学工具来检验以下假说,即 Kv7.4 通道有助于肾血管中的β-肾上腺素能受体介导的血管舒张,并构成自发性高血压大鼠中的血管缺陷的基础。定量 PCR 和免疫组织化学证实了 KCNQ1、KCNQ3、KCNQ4、KCNQ5 和 Kv7.1、Kv7.4 和 Kv7.5 在大鼠肾动脉中的基因和蛋白表达。异丙肾上腺素产生浓度依赖性的预收缩肾动脉舒张,并增加分离平滑肌细胞中的 Kv7 通道电流。Kv7 阻断剂林匹啶的应用减弱了异丙肾上腺素诱导的舒张和电流。用靶向 KCNQ4 的小干扰 RNA 孵育的动脉中,异丙肾上腺素诱导的舒张也减少,这导致 Kv7.4 蛋白水平降低约 60%。来自自发性高血压大鼠的动脉对异丙肾上腺素和 Kv7 激活剂 S-1 的舒张作用被消除,这与 Kv7.4 丰度降低约 60%有关。这项研究首次提供了证据表明 Kv7 通道有助于肾血管中的β-肾上腺素能受体介导的血管舒张,并且 Kv7.4 通道的阻断强烈暗示了自发性高血压大鼠中β-肾上腺素能受体途径受损。这些发现可能为动脉功能障碍和高血压之间提供了新的致病联系。